← Back to Search

Intraocular Lens

Model SC9 for Cataract

N/A
Waitlist Available
Research Sponsored by CORD, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare the Model SC9 IOL to a standard IOL to see if the SC9 improves near and intermediate vision.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in Visual Acuity Measurements using the LogMar Scale
Secondary outcome measures
Defocus testing in 0.5D increments from -0.5 to -5.00D

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Model SC9Experimental Treatment1 Intervention
Investigational IOL
Group II: Model LI61SEActive Control1 Intervention
FDA Approved IOL

Find a Location

Who is running the clinical trial?

CORD, LLCLead Sponsor
J Stuart Cumming, M.D.Study ChairCORD, LLC
John Hovanesian, M.D.Study ChairCORD, LLC
2 Previous Clinical Trials
448 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what quantity of medical institutions is this experiment being conducted?

"The current trial is recruiting patients from 13 different sites, including Redding, Boca Raton and Kansas City. To optimise convenience during your involvement in the research protocol, it is recommended to select a local site near you."

Answered by AI

Is recruitment for this trial still open to the public?

"As per clinicaltrials.gov, this experiment is not presently accepting patients - the posting was originally published on May 31st 2017 and modified as recently as March 29th 2022. Nevertheless, 124 other trials are currently recruiting participants."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
Parkhurst NuVision
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)
2017. "Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03179397.
~43 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top